Alvotech: BofA Initiates Buy Rating as Biosimilar Launch Cycle Begins FDA clears Reykjavik plant as biosimilar launches drive commercial growth. Credit: Regeneron Pharmaceuticals/Bayer Subscribe now Already have an account? Sign in.
